This is a preview of subscription content, log in via an institution to check access.
Notes
risk reducing surgery
Reference
Hoskins P, et al. Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian model. Gynecologic Oncology : 28 Jan 2019. Available from: URL: http://doi.org/10.1016/j.ygyno.2019.01.018
Rights and permissions
About this article
Cite this article
Targeted surgery cost effective in prevention of ovarian cancer. PharmacoEcon Outcomes News 822, 33 (2019). https://doi.org/10.1007/s40274-019-5685-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5685-0